These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9158646)

  • 1. Cerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats.
    Nag S; Kilty DW
    Stroke; 1997 May; 28(5):1028-34. PubMed ID: 9158646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of extracellular matrix proteins in cerebral vessels in chronic hypertension.
    Nag S
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):381-8. PubMed ID: 8786397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling.
    Ledingham JM; Laverty R
    J Hypertens; 1998 Dec; 16(12 Pt 2):1945-52. PubMed ID: 9886881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of enalapril on cerebral circulation and its autoregulation in hypertensive rats].
    Adzhienko LM; Asiedu DI
    Biull Eksp Biol Med; 1999 Jun; 127(6):642-4. PubMed ID: 10445129
    [No Abstract]   [Full Text] [Related]  

  • 10. Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril.
    Schoemaker RG; Leenen FH; Harmsen E
    J Mol Cell Cardiol; 1994 May; 26(5):649-60. PubMed ID: 8072019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension.
    Baumbach GL; Chillon JM
    J Hypertens Suppl; 2000 May; 18(1):S7-11. PubMed ID: 10939784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats.
    Trauernicht AK; Sun H; Patel KP; Mayhan WG
    Stroke; 2003 Nov; 34(11):2698-703. PubMed ID: 14563973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Rossini C; Muiesan ML; Paini A; Duse S; La Boria E; Semeraro F; Cancarini A; Rosei CA; Sarkar A; Ruggeri G; Caimi L; Ricotta D; Rizzoni D; Rosei EA
    J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of candesartan and enalapril on augmented vasoconstrictive responses to endothelin-1 in coronary vessels of spontaneously hypertensive rats.
    Miki S; Takeda K; Hatta T; Harada S; Kido H; Oguni A; Moriguchi J; Morimoto S; Kawa T; Sasaki S; Nakagawa M
    Am J Hypertens; 2002 Mar; 15(3):286-90. PubMed ID: 11939622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.